Accelerator Directory / Institute Of Cancer Research: Royal Cancer Hospital (the)
Business Description
We are world leaders in identifying cancer genes, discovering cancer drugs and developing precision radiotherapy. Together with our hospital partner The Royal Marsden NHS Foundation Trust, we are rated in the top four centres for cancer research and treatment worldwide.
As well as being as world-class research institute, the ICR is a higher education institution and a college of the University of London. We came top in the league table of university research quality compiled from the Research Excellence Framework (REF 2014).
The ICR has charitable status and relies on support from partner organisations, charities, donors and the general public.
The ICR is led by Chief Executive, Professor Paul Workman — an expert in cancer drug discovery.
The majority of ICR employees are directly engaged in research, but there are also important roles in scientific facilities, academic services, IT, fundraising, communication, human resources, and within our Enterprise unit, which negotiates collaborations between ICR scientists and industry.
The Enterprise Unit acts as the technology and knowledge transfer hub for The Institute of Cancer Research, providing the experience and expertise to put in place a wide range of agreements between our scientists and industry.
Although it is not our primary objective, the ICR has been extremely successful in getting a financial return from the commercial exploitation of its research. This income is largely ploughed back into scientific research at the ICR.
We currently have a number of partnering and licensing opportunities in therapeutics, targets, diagnostic biomarkers, devices, and platform or software applications."
Twitter Feed
The ICRICR_London
RT @ICR_CTSU: We are currently recruiting for a number of different statistical roles within ICR-CTSU - find out more and apply here: https…
The ICRICR_London
#ICRjobs The ICR is seeking to appoint an exceptional Team Leader to join the @BreastCancerNow Toby Robins Research… https://t.co/BcE0xiVhYD
The ICRICR_London
The ICR has issued a statement in response to the @US_FDA's approval of #talazoparib for women with BRCA-mutant adv… https://t.co/0jnnlmE101
The ICRICR_London
#ICRprofile Dr Olivia Rossanese investigates new therapeutic targets for the treatment of cancer… https://t.co/8WP78PF20K
The ICRICR_London
Read more about the work of Professor Ros Eeles' Oncogenetics Team: https://t.co/q2YELRN76y https://t.co/Lz6QmHHAbe
The ICRICR_London
#ICRjobs Team Leader in Drug Discovery Biology for Paediatric Brain Tumours. This is a unique opportunity to establ… https://t.co/Yfo4qU5Kr5
The ICRICR_London
@officepowerltd Good luck and thanks for supporting us!
The ICRICR_London
Read the inspiring story of how Matt rode 250km across Norway and Sweden on a husky sled to live by his late grandf… https://t.co/xOCI0Or9kp
The ICRICR_London
BLOG: Professor Chris Lord (@IcrLordLab), has given his inaugural lecture to mark his promotion to Professor after… https://t.co/TBJ1Fdrtc9
